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Abstract
Background: Mental Health First Aid (MHFA) is a mental health intervention that teaches people how to identify,
understand and help someone who may be experiencing a mental health issue. Reviews of the implementation of
MHFA found between 68 and 88% of trained Mental Health First Aiders had used their skills when in contact with
someone experiencing mental health difficulties. Reviews evaluating the impact of MHFA suggest positive
outcomes. However, to date, there has been no systematic, rigorous evaluation of the impact of MHFA on
recipients of the intervention, the organisations providing it and the cost-effectiveness of MHFA overall. This trial
will evaluate the effectiveness and cost-effectiveness of MHFA.
Methods: The study is a multi-centred, two-arm clustered randomised controlled trial. Organisations will be
randomly allocated to the control or intervention (estimated sample size 800 recipients). The intervention is the
standard MHFA intervention provided by Mental Health First Aid England (MHFAE). The control condition will be
organisations having a brief consultation from MHFAE on promoting mental health and well-being in the
workplace. The primary outcome is health seeking behaviour, measured using the Actual Help Seeking
Questionnaire, at 6 months’ follow-up. Data collection will be undertaken at baseline (T0), post-intervention—up to
3 months (T1), at 6 months (T2), 12 months (T3) and 24 months (T4). The primary analysis will be conducted on
those participants who receive MHFA, a per protocol analysis.
Discussion: The study is the first to evaluate the effect of MHFA in the workplace on employees with direct and
indirect experience of the intervention, when compared with usual practice. Being also the first to assess,
systematically, the social impact of MHFA and investigate its cost-effectiveness adds to the originality of the study.
The study promises to yield important data, as yet unknown, regarding the effectiveness, cost-effectiveness,
implementation issues, and the sustainability of MHFA in the workplace.
Trial registration: Clinicaltrials.gov NCT04311203. Registered on 17 March 2020.
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Introduction
Background and rationale {6a}
Mental Health First Aid (MHFA) is a mental health
intervention on how to identify, understand and help
someone who may be experiencing a mental health
issue. It is designed to help Mental Health First-Aiders
to listen, reassure and respond, even in a crisis—and po-
tentially stop a crisis from happening. MHFA courses
were developed in 2000 to equip trainees with first-aid
skills to support people with mental health problems [1].
MHFA training is reported to increase trainees’ know-
ledge, confidence and skills in identifying mental health
problems, as well as reducing negative attitudes and
stigma [1–4].
Reviews of the implementation of MHFA found
between 68 and 88% of trained mental health first aiders
had used their skills when in contact with someone
experiencing mental health difficulties [5–7]. Mental
health interventions in the workplace have been linked
to increased productivity, reduced levels of absenteeism
and significant economic gains [8].
Recently, a large study (MENTOR) [9] investigated the
implementation, use and utility of MHFA in the
workplace using multiple research methods and
reported that MHFA was useful for raising awareness of
mental health in the workplace, but stated it may not be
the best or only means of doing so and may not
necessarily be the most cost-effective. The MENTOR
study highlighted implementation issues relating to lack
of clarity around the role of the mental health first aider
and potential safety concerns, leading them to recom-
mend further research and evaluation of the interven-
tion. Implementation challenges such as role conflict
relating to a person carrying out the first aider role ver-
sus other roles and responsibilities they may have within
the organisation have been identified previously [10].
Handling the potentially hierarchical relationship be-
tween the mental health first aider and recipient, who
may be a subordinate, is one such example of this poten-
tial role conflict [10].
Since the original research on MHFA, in 2001, there
have been numerous studies evaluating MHFA among
various populations, with benefits evident in adults and
young people, across diverse organisations. However,
there is limited evidence from studies conducted outside
Australia, where the research was first conducted. Little
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evidence has shed light on the challenge of
implementing MHFA in a range of organisations, and
there is no evidence establishing the cost-effectiveness of
MHFA, especially when compared to other ways of pro-
viding mental health and well-being support in the
workplace. Few studies test the effect of MHFA directly
on recipients. In addition, no empirical studies have dir-
ectly investigated its wider social impact. MHFA appears
to reduce mental health stigma in the workplace [1, 2,
9], and the potential of MHFA to reduce stigma and
lower sickness absence and presenteeism in the work-
place [8] speaks to wider social benefits such as keeping
people in work and reducing discrimination. However,
the lack of a social impact assessment of MHFA remains
a significant gap in the evidence base.
In sum, evidence suggests MHFA benefits’ organisations
by giving employees the tools to keep themselves and
their colleagues healthy and facilitating a long-term cul-
tural change across organisations. However, there has
been no systematic investigation of the impact of MHFA
on recipients of the intervention, the organisations that
provide MHFA and the cost-effectiveness of MHFA. Fur-
thermore, the wider societal impact of MHFA is not evi-
dent from the empirical literature.
Objectives {7}
The EMPOWER study will implement a cluster
randomised controlled trial (RCT) to examine the
effectiveness and cost-effectiveness of MHFA in the
workplace on help-seeking behaviours of employees,
with embedded qualitative, process and social impact
evaluations. In order to best answer questions regarding
effectiveness, mechanisms and acceptability/feasibility, a
design combining a RCT with a qualitative component
will be adopted. The qualitative component will assess
the efficiency, utility, usability, feasibility, acceptability
and the mechanisms underlying the intervention. This
protocol describes the trial element of EMPOWER.
Trial design {8}
The study is a multi-centred two-arm cluster RCT com-
paring organisations implementing MHFA (intervention
arm) with a consultation on mental health and wellbeing
in the workplace (control arm).
Methods: participants, interventions and
outcomes
Study setting {9}
Data will be collected from employees working in
eligible UK organisations expressing an interest to
MHFAE in undertaking MHFA training.
Eligibility criteria {10}
Inclusion criteria are as follows: organisations expressing
an interest (directly to MHFAE) in undertaking MHFA
training, who have not undertaken this training
previously and who agree to participate and are able to
provide data on sickness absenteeism, presenteeism and
other productivity data. For the purposes of this study,
participants will be all employees working in each
organisation who provide help-seeking outcome data.
Exclusion criteria are as follows: organisations who
have already introduced MHFA across all sites and
departments; those who decline to participate in
adopting MHFA training; and organisations, employees,
mental health first-aiders and recipients who partici-
pated in the pilot study.
The intervention will be delivered by qualified
MHFAE trainers.
Who will take informed consent? {26a}
The research team will elicit written agreement to
participate from a relevant Senior Manager in each
organisation. All employees within each included
organisation will be invited to participate and be
provided with a participant information sheet (PIS)
providing detailed information and procedures regarding
the study. The information provided will include the
following: the benefits and potential harm of
participation; how the team will collect, store and
process data; and the participant’s right to withdraw
from the study at any time, at least 2 weeks prior to any
outcome assessment. Participant consent will be sought,
using Qualtrics, before completing the online survey.
Additional consent provisions for collection and use of
participant data and biological specimens {26b}
N/A
Interventions
Explanation for the choice of comparators {6b}
The control arm is termed as usual practice and is
defined as an organisation that has not previously
introduced MHFA and agrees to not introduce the 2-day
MHFA training during the period of the study. The or-
ganisations allocated to usual practice arm will receive a
brief consultation from MHFAE on the promotion of
mental health and wellbeing in the workplace.
Intervention description {11a}
The MHFA intervention has three parts:
1. The 2-day MHFA training provided by MHFAE.
This is a manualised training programme designed
to provide individuals with the following: an in-
depth understanding of mental health and the
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factors that can affect wellbeing, practical skills to
spot the triggers and signs of mental health issues,
confidence to step in, reassure and support a person
in distress, enhanced interpersonal skills such as
non-judgemental listening, knowledge to help some-
one recover their health by guiding them to further
support—whether that is self-help resources,
through their employer, the NHS, or a
combination.
2. Raising awareness of the presence of MHFA in the
organisation.
3. The application of MHFA to participants in the
workplace. The MHFA training uses a manualised
five-stage approach, ALGEE: Approach the person,
assess and assist with any crisis; Listen and commu-
nicate non-judgementally; Give support and infor-
mation; Encourage the person to get appropriate
professional help and Encourage them to seek other
forms of support.
MHFAE recommend training one employee in MHFA
per ten employees; however, organisations are free to
ask for any number of employees to be trained. The
current study will record the ratio of participants trained
in each organisation. No stipulation is made as to the
selection of participants to be trained, and organisations
are encouraged to advertise the training to all staff. The
selection criteria used by each organisation will be
assessed in the qualitative component of this study.
Criteria for discontinuing or modifying allocated
interventions {11b}
A Trial Steering Committee (TSC), which will audit the
conduct of the study, will have ultimate responsibility
for deciding if the trial should be stopped on grounds of
safety or efficacy. The occurrence of serious adverse
events to participants will be assessed by the TSC and
may be grounds for discontinuing the trial.
Strategies to improve adherence to interventions {11c}
A sample of MHFA training, staggered throughout the
trial, will be observed by two independent researchers
using structured observation forms to assess variability
in fidelity between instructors, sites, and over time. This
will ensure all interventions are being delivered as per
protocol, to equally high standards, to improve
participant adherence.
Relevant concomitant care permitted or prohibited during
the trial {11d}
Organisations in the control arm must agree not to
adopt MHFA training until after the study period.
Provisions for post-trial care {30}
Participants will be debriefed and provided with a
written report of the outcomes containing contact
details of the research group should they require further
information.
Outcomes {12}
Primary outcome
The primary outcome is Employees’ help-seeking behav-
iour at 6 months measured by the Actual Help-Seeking
Questionnaire [AHSQ] [11]. The AHSQ measures help-
seeking behaviour in the 2 weeks preceding the assess-
ment and will be assessed at baseline, 6, 12 and 24
months. Help-seeking behaviour is determined by listing
the number of help sources, the type of help sought and
whether help seeking has occurred during the allocated
time period.
The primary analysis will be conducted on those
participants who receive MHFA and therefore is a per
protocol analysis. Further analyses will examine the
impact of the intervention at the organisational level
using an intention-to-treat analysis with all respondents
included.
As this is a small non-random subsample of rando-
mised participants, it is recognised that this analysis will
be vulnerable to selection bias and uncontrolled con-
founding. For this reason, a range of baseline participant
characteristics will be included in the primary analysis to
mitigate these limitations.
Secondary outcomes
All secondary outcomes and their measures are
described in Table 1. In addition to these outcome
measures, the researchers will also capture data on
organisations’ sickness absence levels, presenteeism rates
and measures of productivity.
Assessment of cost-effectiveness
This component will answer the research question ‘Is
MHFA more cost-effective than usual practice?’ This re-
quires comprehensive estimates of the financial benefits
derived from MHFA and its costs. Consequently, the
evaluation will analyse the data from three perspectives
reflecting the three main groups impacted by MHFA:
– Personal (employees’ quality of life)
– State/government (use of health and social services)
– Employers (staff productivity)
Data will be combined with unit cost data to provide a
financial estimate of the change in service use observed.
The results for those who had the MHFA training and
those who did not will determine whether it is more
cost-effective to purchase the training or not.
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Participant timeline {13}
Sample size {14}
The sample size calculation is based on a simplification
of the proposed analysis model (Fig. 1).
To be able to detect a change of two additional
help seeking resources [11], with 80% power at the
0.05 alpha level, assuming that the mean in the
control group is 1 and in the intervention group 3
with a common standard deviation of 8, 506
participants are required, increasing to 596 allowing
for 15% attrition at 6 months. Pilot data indicates a
response rate of 40% across organisations and an
average cluster size of 72 employees (calculated from
organisations currently signed up) therefore
approximately 29 employees per organisation (cluster
size). With 24 clusters, 12 organisations per
condition, and assuming an intraclass correlation
coefficient (ICC) equal to 0.01 (ICC’s are lower for
participant outcomes as opposed to process variables,
when cluster size is large and when estimates are
adjusted by participant baseline characteristics [21]), a
minimum target sample size is 763, rounded up to
800, 400 per condition
Recruitment {15}
Organisations expressing an interest (directly to MHFA
E) in undertaking MHFA training, who are willing to
take part in the study, will be asked to contact Graham
Durcan (GD: Centre for Mental Health) for detailed
information about the study. Then, if willing to take
part, the Senior Manager will sign a written agreement
and their contact details will be sent to the research
team. The research team will email the Senior Manager,
detailing what will happen next, asking for company
demographics (see secondary outcomes below) and
requesting they send a standard email to ALL employees
providing information about the study with a link to
the survey for completion of baseline measures. One,
2 and 3 weeks later, the research team will send the
Senior Manager another standard email, to be sent to
ALL employees, as a gentle reminder to complete the
survey.
At each follow-up, the research team will send partici-
pants (Senior Managers) up to four weekly email re-
minders to remind employees to complete measures.
Assignment of interventions: allocation
Sequence generation {16a}
Concealment mechanism {16b}
Implementation {16c}
Randomisation
The unit of randomisation is organisation, and
randomisation of organisations will be stratified by size
of organisation, with three strata being defined [22],
small (< 50 employees), medium (50–249 employees)
and large (> 250 employees). The randomisation
schedule will be generated by GD using Random.org
(https://www.random.org/randomness/) and allocation
assigned to an organisation after completion of baseline
measures.
Assignment of interventions: blinding
Who will be blinded {17a}
Participants, mental health first aiders and researchers
will not be blinded to treatment allocation due to the
nature of the study. However, independent staff helping
to process the data, the trial statistician and health
economist will all be blinded to intervention status.
Table 1 Data collection schedule and secondary outcome measures
Measure Timing of measures
Baseline Post-intervention
(up to 3 months)
6 months 12 months 24 months
Demographics (age, gender, level of education, ethnicity, nature and
frequency of and MHFA interventions directly experienced, etc.)
X
Employees help-seeking intentions (General Help-Seeking Questionnaire) [12] X X X X X
Employees’ mental health and wellbeing (Warwick-Edinburgh Mental
health and Well-being Scale) [13]
X X X X X
Mental health first aiders’ mental health literacy (Mental Health Literacy Scale) [14]a X X X X X
Mental health first aiders’ skills (ALGEE scoring system) [15]a X X X X X
Employees’ quality of life (EQ-5D-5L and Short Form-12 Health Survey SF-12) [16] X X X X X
Employees’ self-efficacy (Self-Efficacy for Seeking Mental Health Care Scale) [17, 18] X X X X X
Employees’ social well-being (Social Well-being Scale) [19] X X X X X
Employees’ use of standard mental health and other services (adapted
version of the Client Services receipt Inventory) [20]
X X X X X
aIntervention group
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Procedure for unblinding if needed {17b}
N/A due to the nature of the trial.
Data collection and management
Plans for assessment and collection of outcomes {18a}
Consent, baseline and follow-up data will be collected
online, with the option for employees to complete them
in hard copy should they be unable to complete them
online. The research team will email the designated con-
tact from each organisation, giving instructions and in-
formation for them to send to ALL employees and a link
to the survey. One, 2 and 3 weeks later, follow-up emails
will be sent to the same contact, asking them to send a
reminder email, with a repeat survey link. After this
period, participants who have not completed the survey
will be treated as lost to follow-up.
Plans to promote participant retention and complete
follow-up {18b}
Participants will be sent up to four weekly reminders to
complete the survey at each time point.
Data management {19}
Participant data will be exported from Qualtrics into
SPSS version 22 by the research team (and any hard
copies entered manually), stored on a password-
protected network drive, will be accessible only to re-
search team members and will only be linked directly
with their participant ID code.
Confidentiality {27}
Stored data will only be linked directly with the
participant ID code. Any hard copies of data will be
Fig. 1 CONSORT trial flow diagram
Atanda et al. Trials          (2020) 21:715 Page 6 of 9
destroyed by confidential waste disposal 15 years after
the research findings have been published. Electronic
copies of data will be stored in two archives. In both
cases, only anonymous data will be archived at London
South Bank University archive and a national data
repository.
Plans for collection, laboratory evaluation and storage of
biological specimens for genetic or molecular analysis in
this trial/future use {33}
N/A as no biological specimens were collected as part of
this trial.
Statistical methods
Statistical methods for primary and secondary outcomes
{20a}
All outcomes will be described with the appropriate
descriptive statistics: mean and standard deviation for
continuous outcomes (or medians and interquartile
range for skewed data) and counts and percentages for
dichotomous and categorical outcomes.
The analysis of the primary outcome will estimate
the mean difference (with 95% confidence intervals)
in the Actual Help-Seeking score at 6-month follow-
up between the intervention (MHFA) and standard
care groups using a mixed effects repeated measures
model (which assumes incomplete outcome data to
be missing at random). The model will incorporate
demographic and other baseline covariates as fixed ef-
fects. The dependent variable will be the count of
help sources on the Actual Help-Seeking question-
naire. The independent variable will be ‘time point’.
The effect size of the intervention will be estimated
as the exponentiated coefficient for the interaction
term between time point (baseline versus 6-month
follow-up) and intervention status (MHFA versus con-
trol group). A random effect of participant will be in-
cluded in the model to adjust for the repeated
measures on participants. ‘Employing organisation’
will be included as a higher level random effect (with
participants nested in employers). Statistical signifi-
cance will be at the 5% level.
Secondary outcomes will be analysed using an
appropriate generalised linear model, for example binary
logistic regression for dichotomous outcomes and
ordinal logistic regression for ordered categorical
outcomes. All models will be adjusted for employing
organisation and baseline score (where applicable).
Interim analyses {21b}
There will be no interim analyses.
Methods for additional analyses (e.g. subgroup analyses)
{20b}
Age, gender, level of education, ethnicity, nature and
frequency of MHFA interventions directly experienced
will be included in the primary analysis as covariates.
Methods in analysis to handle protocol non-adherence
and any statistical methods to handle missing data {20c}
The missing at random assumption for primary outcome
data will be assessed further in sensitivity analyses.
Treatment effects will be estimated under varying
assumptions of data being missing not at random using
pattern-mixture models. A complete case analysis will
also be conducted.
Plans to give access to the full protocol, participant-level
data and statistical code {31c}
Access to the full protocol, participant-level data and
statistical code will be available from the OSF.
Oversight and monitoring
Composition of the coordinating centre and Trial Steering
Committee {5d}
Graham Durcan from The Centre for Mental Health
(CMH) has oversight of the project management on
behalf of the funders. The Chief Investigator [CI]
(Callaghan) has overall responsibility for the research.
A Research Management Group (RMG), which the CI
will chair, comprising all authors, will advise and assist
on the project’s management. The RMG meets every 6
weeks.
An Expert Reference Group (ERG), a group of
independent research experts and lay people and the CI,
will provide subject matter expertise to the funders and
work with the CMH and London South Bank
University’s representatives to guide and oversee the
impact of the research. The ERG meets quarterly for the
entirety of the project’s duration.
Composition of the data monitoring committee, its role and
reporting structure {21a}
Data monitoring will be conducted by the Trial Steering
Committee (TSC) comprising a trialist, statistician and
health economist and will act as Data Safety Monitoring
Board (DSMB). The TSC will oversee the conduct of the
trial independently of and on behalf of the project
funders and sponsors and ensure it is carried out with
reference to good practice. The TSC will have ultimate
responsibility for deciding if the trial should be stopped
on grounds of efficacy. The TSC is a sub-group of the
project Expert Reference Group (ERG) set up by the
funders and will audit the trial conduct through reports
submitted to it by the researchers on a three-monthly
basis.
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Adverse event reporting and harms {22}
We anticipate little risk to participants in the study. The
Senior Manager in each company will be asked to report
to the CI in writing any adverse or untoward incidents
that occur because of the study. The CI will assess each
adverse event and decide on an appropriate course of
action. In case of serious adverse events (SAEs), i.e.
those causing serious injury or death, the CI will notify
the Ethics Committee and the TSC as soon as possible
after being notified. A TSC within the ERG consisting of
members independent of the investigators, their
employing organisations, funders and sponsor will
monitor trial progress and conduct and will have
ultimate responsibility for deciding if the trial should be
stopped on the grounds of safety.
Frequency and plans for auditing trial conduct {23}
The Trial Steering Committee (TSC) will audit the trial
conduct.
Plans for communicating important protocol amendments
to relevant parties (e.g. trial participants, ethical
committees) {25}
Important changes to the protocol will be reported to
the funders, the trial registry, the TSC and the ethics
committee. The latter will need to approve any changes.
Dissemination plans {31a}
We will engage potential adopters throughout the life of
the project to enable transfer of project outcomes and
effective pathways to impact through educational
outreach visits to companies and other services and
interactive educational meetings through discussion
forums involving the research team and local opinion
leaders in each site to influence dissemination. We will
publish papers in high impact journals, professional
magazines, newsletters of Non-Governmental agencies
and presentations to policy makers, roundtable discus-
sions and a final conference. We will create and main-
tain a project website and establish a newsletter,
monthly blogs and a quarterly update bulletin diffused
via various social media.
Discussion
The study is the first to evaluate the effect of MHFA in
the workplace on employees with direct and indirect
experience of the intervention, when compared with
usual practice. Being also the first to assess,
systematically, the social impact of MHFA and
investigate its cost-effectiveness adds to the originality of
the study. The study promises to yield important data,
as yet unknown, regarding the effectiveness, cost-
effectiveness, implementation issues and the sustainabil-
ity of MHFA in the workplace.
Trial status
Participants are being actively recruited for this trial.
Recruitment for the trial began in January 2020 and is
expected to continue until January 2021. This
manuscript describes Version 18 of the study protocol,
dated 24 June 2020.
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